Katja Weisel

39PUBLICATIONS

200CO-AUTHORS

Gene and molecular therapyMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pharmacogenomics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (39)

Sort by Publication Date:

|Jul 06, 2026

Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

|Jun 25, 2026

Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.

|May 21, 2026

Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

|May 13, 2026

Experiences and expert panel consensus on bridging therapy before anti-BCMA CAR-T cell therapy in multiple myeloma.

|Apr 06, 2026

Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial.

Francesca Gay, Wilfried Roeloffzen, Meletios A Dimopoulos

|Apr 01, 2026

Effectiveness of linvoseltamab versus real-world standard-of-care in triple-class-exposed relapsed/refractory multiple myeloma in the United States.

Shaji Kumar, Katja C Weisel, Paul Spin

Pageof 7

Frequent Collaborators

18 joint publications

Hartmut Goldschmidt

14 joint publications

Marc S Raab

12 joint publications

Elias K Mai

11 joint publications

María-Victoria Mateos

11 joint publications

Hans Salwender

10 joint publications

Niels Weinhold

Lisa B Leypoldt

Saad Z Usmani

Hermann Einsele

Carsten Müller-Tidow

Frequent Collaborators

18 joint publications

Hartmut Goldschmidt

14 joint publications

Marc S Raab

12 joint publications

Elias K Mai

11 joint publications

María-Victoria Mateos